Soluble Fas and Soluble Fas Ligand Proteins in Human Milk: Possible Significance in the Development of Immunological Tolerance
- 5 January 1999
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 49 (1) , 51-54
- https://doi.org/10.1046/j.1365-3083.1999.00464.x
Abstract
Human milk contains a complex uncharacterized, immune system able to exert actions both locally and systemically. This study reports the results of an ELISA-based quantitation of soluble Fas and soluble Fas ligand in human milk which may modulate the Fas/FasL system that is critical for the expression of immune tolerance and apoptosis. Production of Fas/FasL mRNAs by milk cells was also examined using RT–PCR. Fas is ubiquitously expressed in various cells and when bound by its ligand FasL, present predominantly on activated T- and NK cells, Fas-expressing cells are killed. A large amount of soluble Fas (1746–4320 pg/ml) is detected in colostrum, transitional milk and the mature milk of mothers delivering prematurely or at full-term, whereas FasL is present only in the range 123–310 pg/ml. Milk cells are positive for Fas mRNA, but negative for FasL mRNA. An excess of soluble Fas in human milk may bind to FasL preventing apoptosis and preserving epithelial barriers, and may represent an additional new mechanism whereby human milk favours immune tolerance and normal gastrointestinal development.Keywords
This publication has 17 references indexed in Scilit:
- The Role of Breast Milk in the Development of the Gastrointestinal TractNutrition Reviews, 2009
- To Die or Not to DieJAMA, 1998
- REGULATION OF FAS AND FAS-LIGAND EXPRESSION IN NK CELLS BY CYTOKINES AND THE INVOLVEMENT OF FAS-LIGAND IN NK/LAK CELL-MEDIATED CYTOTOXICITYCytokine, 1997
- Apoptosis by Death FactorCell, 1997
- Special Properties of Human MilkClinical Pediatrics, 1996
- Metalloproteinase-mediated release of human Fas ligand.The Journal of Experimental Medicine, 1995
- Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years oldThe Lancet, 1995
- Fas ligand mediates activation-induced cell death in human T lymphocytes.The Journal of Experimental Medicine, 1995
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- HUMAN COLOSTRAL AND BREAST MILK CELLS A Light and Electron Microscopic StudyActa Paediatrica, 1979